Pharm-MD; an open-label, randomized controlled, phase II study to evaluate the efficacy of a pharmacist-managed diabetes clinic in high-risk diabetes patients – study protocol for a randomized controlled trial

BACKGROUND: Millions of Americans are currently living with diabetes and approximately 1.5 million cases are being diagnosed each year. Diabetes is now the seventh leading cause of death in the United States. In addition, the economic burden of the disease has resulted in billions of dollars in heal...

Descripción completa

Detalles Bibliográficos
Autores principales: Halalau, Alexandra, Shelden, Daniel, Keeney, Scott, Hehar, Jaspreet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6109355/
https://www.ncbi.nlm.nih.gov/pubmed/30143033
http://dx.doi.org/10.1186/s13063-018-2836-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6109355/
https://www.ncbi.nlm.nih.gov/pubmed/30143033
http://dx.doi.org/10.1186/s13063-018-2836-8

Ejemplares similares